Evaluation of sequential organ failure assessment (SOFA) score efficiency in predicting the mortality of intensive care unit admitted COVID-19 patients

Mohammad Haghighi, Hossein Khoshrang, Siamak Rimaz, Tofigh Yaghubi Kalurazi, Zahra Atrkar Roushan, Samaneh Ghazanfar Tehran, Paniz Rezaei, Niloofar Faraji


Assessing the severity of the disease at the time of hospitalization can reduce the mortality of patients with coronavirus disease 2019 (COVID-19). For this stance, various scoring systems have been described to predict mortality rates. Sequential organ failure assessment (SOFA) is one of the scoring systems which have been used in this study. In order to calculate the SOFA score, demographic and characteristics information, clinical status, and laboratory findings were recorded from 154 patients with COVID-19, who have been admitted to the intensive care unit (ICU) for a period of 6 months. SOFA score was calculated in three time periods at the time of hospitalization, 72 hours after hospitalization, and the last day of hospitalization. Based on the outcome of the disease (death or recovery), patients were divided into two groups, and the results were analyzed in both groups. Statistical analysis has represented that the SOFA score was significantly higher in patients who died to compare with recovered ones in all time periods. Our findings suggest that SOFA scoring system can be used to predict mortality rate in ICU admitted COVID-19 patients.


COVID-19; SOFA score; ICU; Mortality


Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020; 395(10223):507-13.

Guo YR, Cao QD, Hong ZS, Tan YY, Chen SD, Jin HJ, et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status. Mil Med Res. 2020; 7(1):11.

Abdelrahman Z, Li M, Wang X. Comparative Review of SARS-CoV-2, SARS-CoV, MERS-CoV, and Influenza A Respiratory Viruses. Front Immunol. 2020; 11:552909.

Han H, Yang L, Liu R, Liu F, Wu KL, Li J, et al. Prominent changes in blood coagulation of patients with SARS-CoV-2 infection. Clin Chem Lab Med. 2020; 58(7):1116-20.

Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020; 8(5):475-81.

Bhatraju PK, Ghassemieh BJ, Nichols M, Kim R, Jerome KR, Nalla AK, et al. Covid-19 in Critically Ill Patients in the Seattle Region - Case Series. N Engl J Med. 2020; 382(21):2012-22.

Chen Q, Xu L, Dai Y, Ling Y, Mao J, Qian J, et al. Cardiovascular manifestations in severe and critical patients with COVID-19. Clin Cardiol. 2020; 43(7):796-802.

Choudry FA, Hamshere SM, Rathod KS, Akhtar MM, Archbold RA, Guttmann OP, et al. High T

DOI: https://doi.org/10.52547/JCBioR.2.4.168


  • There are currently no refbacks.

Copyright (c) 2021 © The Author(s)

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.